Suzanne Conzen to Disease Progression
This is a "connection" page, showing publications Suzanne Conzen has written about Disease Progression.
Connection Strength
0.296
-
The role of adrenergic signaling in breast cancer biology. Cancer Biomark. 2013; 13(3):161-9.
Score: 0.077
-
The influence of glucocorticoid signaling on tumor progression. Brain Behav Immun. 2013 Mar; 30 Suppl:S26-31.
Score: 0.076
-
The Role of Psychologic Stress in Cancer Initiation: Clinical Relevance and Potential Molecular Mechanisms. Cancer Res. 2021 10 15; 81(20):5131-5140.
Score: 0.035
-
Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer. Clin Cancer Res. 2018 07 15; 24(14):3433-3446.
Score: 0.028
-
Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions. Gynecol Oncol. 2017 12; 147(3):672-677.
Score: 0.027
-
Mammary cancer initiation and progression studied with magnetic resonance imaging. Breast Cancer Res. 2014 Dec 16; 16(6):495.
Score: 0.022
-
Phase II trial of temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2012 Nov; 136(2):355-63.
Score: 0.018
-
Magnetic resonance imaging of the natural history of in situ mammary neoplasia in transgenic mice: a pilot study. Breast Cancer Res. 2009; 11(5):R65.
Score: 0.015